NEW YORK (Reuters Health) – The combination of the cholesterol uptake inhibitor ezetimibe and a statin is more effective than a statin alone for reducing LDL cholesterol in…
NEW YORK (Reuters Health) – Lipid-lowering therapy reduces cardiovascular events and all-cause mortality in patients with atrial fibrillation, according to a post hoc analysis of the AFFIRM study.…
NEW YORK (Reuters Health) – Endovascular therapy for acute ischemic stroke is at least as safe in nonintubated versus intubated patients, a small, retrospective study shows. As reported…
Protein energy malnutrition can cause death in post-operative and cancer patients. New protein-rich snacks can help remedy that situation, and offer a new solution for cancer patients undergoing…
NEW YORK (Reuters Health) – Patients with a textbook case of “typical” angina are no more likely than patients with atypical or nonanginal chest pain to have inducible…
NEW YORK (Reuters Health) – Patients with macroprolactinemia don’t need extensive exams or prolonged monitoring, according to a prospective study. As long as their monomeric prolactin concentration is…
NEW YORK (Reuters Health) – A single yearly oral dose of 500,000 international units of cholecalciferol (vitamin D) does not protect generally healthy older women from falls and…
NEW YORK (Reuters Health) – The dopamine agonist pramipexole relieves depressive symptoms in patients with Parkinson’s disease, according to a study published online May 10th in The Lancet…
NEW YORK (Reuters Health) – Mounting evidence suggests that preoperative prostate specific antigen (PSA) kinetics are a poor marker of disease progression. During active surveillance for low-risk, low-volume…
NEW YORK (Reuters Health) – An iPhone with dedicated software for evaluation of coronary CT angiography (CTA) is highly accurate for detecting and excluding significant stenosis, according to…